Sox2 modulates motility and enhances progression of colorectal cancer via the Rho-ROCK signaling pathway
Authors:
Open Access
- 10 October 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (58) , 98635-98645
Abstract
Sox2 modulates motility and enhances progression of colorectal cancer via the Rho-ROCK signaling pathway Sox2 Modulates Motility and Enhances Progression of Colorectal Cancer via the Rho-ROCK Signaling PathwayKeywords
This publication has 33 references indexed in Scilit:
- Increased JNK1 Signaling Pathway Is Responsible for ABCG2-Mediated Multidrug Resistance in Human Colon CancerPLOS ONE, 2012
- Understanding cancer stem cell heterogeneity and plasticityCell Research, 2012
- SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancerBMC Cancer, 2011
- ChIP-seq and Functional Analysis of the SOX2 Gene in Colorectal CancersOMICS: A Journal of Integrative Biology, 2010
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal EvolutionCell, 2009
- Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After ChemoradiotherapyAnnals of Surgical Oncology, 2009
- Dissecting progressive stages of 5‐fluorouracil resistance in vitro using RNA expression profilingInternational Journal of Cancer, 2004
- Regulation and Functions of Rho-Associated KinaseExperimental Cell Research, 2000
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- The small GTP-binding protein rac regulates growth factor-induced membrane rufflingCell, 1992